Charles Carroll Financial Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Charles Carroll Financial Partners's AMGN Position: Q2 2023 in Review
Charles Carroll Financial Partners sold out of Amgen (AMGN) in Q2 2023, closing a stake of 12,615 shares — an estimated $3.05M sold.
Charles Carroll Financial Partners first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $3.31M in Q4 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.
- Charles Carroll Financial Partners reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
- Charles Carroll Financial Partners sold 12,615 Amgen shares in Q2 2023, an estimated $3.05M.
- Charles Carroll Financial Partners first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
- Charles Carroll Financial Partners's Amgen position peaked at $3.31M in Q4 2022.
- 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.
Based on Charles Carroll Financial Partners's 13F filing for Q2 2023, filed 14 Aug 2023.